Target intelligence / Profile preview

Sodium-coupled neutral amino acid transporter 2 (SNAT2)

Target
SNAT2
Molecular classification
Transporter, Solute carrier family, Membrane protein
01

Overview

Sodium-coupled neutral amino acid transporter 2 (SNAT2) is a member of the solute carrier family 38 (SLC38A2). It is a plasma membrane transporter that uses the sodium gradient to mediate the cellular uptake of small, neutral amino acids, including alanine, glutamine, serine, and others. SNAT2 plays a crucial role in nutrient uptake, neurotransmitter cycling (especially in the brain, as part of the glutamate–glutamine cycle), and adaptations to increased proliferative or metabolic demand (such as in cancer cells or during pregnancy in the mammary gland). The transporter is pharmacologically relevant as a potential drug delivery route and, indirectly, as a cancer and metabolic disease target. Modulation of SNAT2 impacts cellular amino acid pools and has downstream effects on cell growth and survival[1][2][3][4][7].

Other names
SLC38A2System A transporter 2solute carrier family 38 member 2SNAT2
02

Mechanism of action

Competitive inhibition (e.g., with MeAIB, a known SNAT inhibitor) Competitive substrate uptake (exploited by amino acid–mimetic prodrugs)

03

Biological functions

Amino acid transportRegulation of amino acid homeostasisGlutamine-glutamate cycling (notably in the central nervous system)Cell proliferation (especially in tissues such as the mammary gland during gestation)Ammonia detoxificationGluconeogenesis
04

Disease associations

Cancer (potential therapeutic and diagnostic relevance)Neurological conditions (by affecting glutamine/glutamate cycles)Other (possible links to metabolic diseases, liver and kidney function regulation)
05

Safety considerations

Possible risk of disrupting systemic amino acid homeostasis if inhibited extensivelyPotential metabolic effects in rapidly proliferating tissues such as tumors, mammary gland, or brain if transporter function is altered
06

Interacting drugs

LAT1-utilizing prodrugs

1 more in the full profile.

07

Biomarkers

SNAT2 expression (as a functional marker for neutral amino acid uptake, potential for use in cancer and tissue-specific nutrient transport studies)

Beyond the preview

Go deeper on Sodium-coupled neutral amino acid transporter 2 (SNAT2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium-coupled neutral amino acid transporter 2 (SNAT2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call